RMD RSI Chart
Last 7 days
-1.0%
Last 30 days
13.4%
Last 90 days
15.9%
Trailing 12 Months
-7.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 4.6B | 0 | 0 | 0 |
2023 | 4.0B | 4.2B | 4.4B | 4.5B |
2022 | 3.5B | 3.6B | 3.6B | 3.8B |
2021 | 3.1B | 3.2B | 3.3B | 3.4B |
2020 | 2.9B | 3.0B | 3.0B | 3.1B |
2019 | 2.5B | 2.6B | 2.7B | 2.8B |
2018 | 2.3B | 2.3B | 2.4B | 2.5B |
2017 | 2.0B | 2.1B | 2.1B | 2.2B |
2016 | 1.8B | 1.8B | 1.9B | 2.0B |
2015 | 1.6B | 1.7B | 1.7B | 1.7B |
2014 | 1.6B | 1.6B | 1.6B | 1.6B |
2013 | 1.5B | 1.5B | 1.5B | 1.5B |
2012 | 1.3B | 1.4B | 1.4B | 1.4B |
2011 | 1.2B | 1.2B | 1.3B | 1.3B |
2010 | 1.0B | 1.1B | 1.1B | 1.2B |
2009 | 0 | 920.7M | 963.6M | 1.0B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index
Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.
Returns of $10,000 invested in:
Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022
Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 29, 2024 | burt carol | gifted | - | - | -234 | - |
Apr 29, 2024 | drexler karen | sold | -91,341 | 214 | -425 | - |
Mar 04, 2024 | rider michael j | sold | -14,580 | 180 | -81.00 | global general counsel |
Mar 01, 2024 | rider michael j | sold | -34,650 | 173 | -200 | global general counsel |
Feb 22, 2024 | farrell peter c | sold | -1,997,430 | 182 | -10,935 | - |
Nov 27, 2023 | sandercock brett | sold | -457,860 | 152 | -3,000 | chief financial officer |
Nov 22, 2023 | rider michael j | gifted | - | - | -72.00 | global general counsel |
Nov 20, 2023 | douglas robert andrew | sold (taxes) | -204,825 | 148 | -1,375 | president and coo |
Nov 20, 2023 | farrell michael j. | sold (taxes) | -350,445 | 148 | -2,352 | chief executive officer |
Nov 20, 2023 | ghoshal kaushik | sold (taxes) | -54,656 | 148 | -366 | president, saas business |
Which funds bought or sold RMD recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 07, 2024 | Swiss National Bank | reduced | -4.22 | 8,120,220 | 87,232,200 | 0.06% |
May 07, 2024 | QRG CAPITAL MANAGEMENT, INC. | new | - | 244,501 | 244,501 | -% |
May 07, 2024 | FORSTA AP-FONDEN | added | 10.57 | 1,243,750 | 5,802,280 | 0.05% |
May 07, 2024 | Inspire Advisors, LLC | added | 10.16 | 125,862 | 594,933 | 0.08% |
May 07, 2024 | Inspire Investing, LLC | added | 5.3 | 630,906 | 3,604,510 | 0.37% |
May 07, 2024 | SEI INVESTMENTS CO | added | 12.92 | 992,824 | 4,299,160 | 0.01% |
May 07, 2024 | Avalon Trust Co | new | - | 18,751,500 | 18,751,500 | 1.54% |
May 07, 2024 | Washington Trust Advisors, Inc. | reduced | -1.08 | 3,255,620 | 26,716,200 | 2.45% |
May 07, 2024 | ClariVest Asset Management LLC | unchanged | - | 93.00 | 785 | -% |
May 07, 2024 | MEEDER ASSET MANAGEMENT INC | new | - | 9,307 | 9,307 | -% |
Unveiling ResMed Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to ResMed Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 182.6B | 40.3B | 32.45 | 4.53 | ||||
BDX | 67.4B | 19.7B | 50.6 | 3.42 | ||||
ALGN | 20.6B | 3.9B | 44.54 | 5.26 | ||||
BAX | 18.2B | 14.9B | 6.88 | 1.22 | ||||
MID-CAP | ||||||||
ATR | 10.0B | 3.5B | 31.94 | 2.82 | ||||
HSIC | 9.3B | 12.5B | 24.01 | 0.75 | ||||
BIO | 7.6B | 2.6B | -23.72 | 2.94 | ||||
XRAY | 5.8B | 3.9B | -61.76 | 1.47 | ||||
AXNX | 3.4B | 387.1M | -215.56 | 8.87 | ||||
PDCO | 2.3B | 6.6B | 11.98 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.85 | 0.4 | ||||
ANIK | 423.5M | 169.3M | -5.51 | 2.5 | ||||
ANGO | 236.7M | 324.0M | -1.23 | 0.73 | ||||
APYX | 45.4M | 52.3M | -2.43 | 0.87 | ||||
AEMD | 3.3M | 3.7M | -0.27 | 0.88 |
ResMed Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 2.9% | 1,197 | 1,163 | 1,102 | 1,122 | 1,117 | 1,034 | 950 | 915 | 865 | 895 | 904 | 876 | 769 | 800 | 752 | 770 | 769 | 736 | 681 | 705 | 662 |
Gross Profit | 7.1% | 693 | 647 | 600 | 617 | 618 | 580 | 541 | 523 | 491 | 504 | 506 | 491 | 447 | 462 | 439 | 449 | 450 | 427 | 392 | 399 | 381 |
Operating Expenses | -14.4% | 318 | 372 | 311 | 342 | 317 | 300 | 265 | 267 | 257 | 256 | 244 | 249 | 224 | 241 | 222 | 226 | 232 | 229 | 221 | 278 | 224 |
S&GA Expenses | 3.5% | 230 | 222 | 223 | 240 | 228 | 212 | 194 | 193 | 182 | 185 | 177 | 181 | 160 | 169 | 159 | 165 | 172 | 171 | 167 | 172 | 165 |
R&D Expenses | 4.3% | 77.00 | 74.00 | 76.00 | 78.00 | 76.00 | 70.00 | 63.00 | 64.00 | 67.00 | 63.00 | 60.00 | 60.00 | 56.00 | 55.00 | 55.00 | 53.00 | 51.00 | 50.00 | 48.00 | 51.00 | 48.00 |
EBITDA Margin | 5.4% | 0.29* | 0.27* | 0.28* | 0.29* | 0.29* | 0.30* | 0.30* | 0.31* | 0.30* | 0.31* | 0.31* | 0.32* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 20.1% | -11.03 | -13.80 | -14.96 | -14.94 | -14.96 | -10.34 | -7.13 | -5.54 | -5.46 | -5.95 | -5.36 | -41.97 | 6.00 | 6.00 | 7.00 | -70.54 | 10.00 | 10.00 | 11.00 | 13.00 | 12.00 |
Income Taxes | 47.9% | 75.00 | 51.00 | 53.00 | 47.00 | 57.00 | 49.00 | 51.00 | 43.00 | 47.00 | 36.00 | 55.00 | 44.00 | 296 | 31.00 | 37.00 | 34.00 | 29.00 | 18.00 | 30.00 | 27.00 | 33.00 |
Earnings Before Taxes | 44.7% | 375 | 259 | 272 | 277 | 289 | 274 | 262 | 238 | 226 | 237 | 259 | 239 | 218 | 211 | 216 | 212 | 192 | 179 | 151 | 96.00 | 138 |
EBT Margin | 6.0% | 0.26* | 0.24* | 0.25* | 0.26* | 0.26* | 0.27* | 0.27* | 0.27* | 0.27* | 0.28* | 0.28* | 0.28* | - | - | - | - | - | - | - | - | - |
Net Income | 43.9% | 300 | 209 | 219 | 230 | 233 | 225 | 210 | 195 | 179 | 202 | 204 | 195 | -78.48 | 180 | 178 | 178 | 163 | 161 | 120 | 69.00 | 105 |
Net Income Margin | 5.8% | 0.21* | 0.20* | 0.21* | 0.21* | 0.21* | 0.22* | 0.22* | 0.22* | 0.22* | 0.15* | 0.15* | 0.15* | - | - | - | - | - | - | - | - | - |
Free Cashflow | 52.7% | 381 | 249 | 256 | 203 | 254 | 101 | 16.00 | 51.00 | 69.00 | 189 | -93.00 | 199 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -1.3% | 6,815 | 6,905 | 6,741 | 6,752 | 6,714 | 6,676 | 5,178 | 5,096 | 4,905 | 4,735 | 4,729 | 4,728 | 4,586 | 4,573 | 4,621 | 4,587 | 4,511 | 4,354 | 4,155 | 4,108 | 4,099 |
Current Assets | -1.1% | 2,351 | 2,378 | 2,305 | 2,368 | 2,338 | 2,325 | 2,034 | 1,931 | 1,704 | 1,547 | 1,586 | 1,575 | 1,466 | 1,451 | 1,543 | 1,523 | 1,470 | 1,300 | 1,161 | 1,145 | 1,103 |
Cash Equivalents | 13.2% | 238 | 210 | 209 | 228 | 228 | 253 | 207 | 274 | 202 | 194 | 276 | 295 | 231 | 256 | 421 | 463 | 353 | 204 | 172 | 147 | 147 |
Inventory | -11.1% | 829 | 933 | 958 | 998 | 1,011 | 989 | 865 | 744 | 665 | 592 | 507 | 457 | 484 | 475 | 478 | 417 | 359 | 378 | 357 | 350 | 320 |
Net PPE | -2.2% | 540 | 552 | 534 | 538 | 529 | 523 | 487 | 498 | 513 | 478 | 467 | 463 | 455 | 459 | 425 | 417 | 397 | 408 | 383 | 387 | 382 |
Goodwill | -0.9% | 2,836 | 2,862 | 2,812 | 2,770 | 2,784 | 2,767 | 1,939 | 1,936 | 1,946 | 1,951 | 1,922 | 1,928 | 1,926 | 1,910 | 1,900 | 1,890 | 1,884 | 1,871 | 1,856 | 1,856 | 1,939 |
Liabilities | -9.8% | 2,185 | 2,423 | 2,490 | 2,622 | 2,781 | 2,938 | 1,745 | 1,735 | 1,626 | 1,589 | 1,703 | 1,842 | 1,876 | 1,708 | 1,942 | 2,090 | 2,254 | 2,096 | 2,037 | 2,035 | 2,077 |
Current Liabilities | 1.2% | 773 | 764 | 771 | 759 | 762 | 733 | 693 | 689 | 667 | 621 | 624 | 912 | 877 | 577 | 591 | 603 | 552 | 500 | 550 | 556 | 463 |
Short Term Borrowings | 0.1% | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 |
Long Term Debt | -18.1% | 997 | 1,217 | 1,352 | 1,431 | 1,576 | 1,791 | 785 | 765 | 669 | 668 | 794 | 643 | 719 | 814 | 1,044 | 1,164 | 1,365 | 1,288 | 1,208 | 1,259 | 1,323 |
Shareholder's Equity | 3.3% | 4,630 | 4,482 | 4,250 | 4,130 | 3,933 | 3,738 | 3,433 | 3,361 | 3,279 | 3,146 | 3,026 | 2,886 | 2,709 | 2,865 | 2,679 | 2,497 | 2,256 | 2,258 | 2,117 | 2,072 | 2,021 |
Retained Earnings | 5.1% | 4,770 | 4,540 | 4,402 | 4,253 | 4,088 | 3,920 | 3,760 | 3,614 | 3,480 | 3,363 | 3,222 | 3,080 | 2,941 | 3,077 | 2,954 | 2,833 | 2,712 | 2,605 | 2,501 | 2,436 | 2,421 |
Additional Paid-In Capital | 1.4% | 1,848 | 1,823 | 1,791 | 1,772 | 1,729 | 1,711 | 1,702 | 1,682 | 1,645 | 1,629 | 1,644 | 1,622 | 1,587 | 1,574 | 1,588 | 1,571 | 1,534 | 1,522 | 1,530 | 1,511 | 1,476 |
Shares Outstanding | -0.1% | 147 | 147 | 147 | 147 | 147 | 147 | 146 | 146 | 146 | 146 | 146 | 145 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | 30,201 | - | - | - | 37,771 | - | - | - | 30,662 | - | - | - | 22,240 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 47.4% | 402 | 273 | 286 | 237 | 283 | 129 | 45.00 | 79.00 | 117 | 220 | -65.66 | 227 | 196 | 170 | 144 | 330 | 240 | 70.00 | 162 | 142 | 140 |
Share Based Compensation | 3.0% | 20.00 | 20.00 | 19.00 | 20.00 | 18.00 | 16.00 | 17.00 | 16.00 | 16.00 | 16.00 | 17.00 | 17.00 | 16.00 | 15.00 | 16.00 | 16.00 | 14.00 | 14.00 | 13.00 | 14.00 | 13.00 |
Cashflow From Investing | 19.4% | -33.15 | -41.14 | -148 | -46.52 | -28.10 | -1,026 | -58.81 | -55.24 | -49.49 | -83.31 | -41.87 | -48.07 | -58.62 | -29.66 | -22.11 | -3.41 | -99.61 | -43.62 | -33.22 | -43.89 | -225 |
Cashflow From Financing | -40.6% | -335 | -238 | -151 | -188 | -279 | 933 | -41.88 | 57.00 | -60.86 | -217 | 93.00 | -114 | -158 | -316 | -175 | -236 | 18.00 | 1.00 | -100 | -97.57 | 83.00 |
Dividend Payments | -0.3% | 70.00 | 71.00 | 71.00 | 65.00 | 65.00 | 65.00 | 64.00 | 61.00 | 61.00 | 61.00 | 61.00 | 57.00 | 57.00 | 57.00 | 57.00 | 56.00 | 56.00 | 56.00 | 56.00 | 53.00 | 53.00 |
Buy Backs | - | 50.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | Mar. 31, 2024 | Mar. 31, 2023 | |
Net revenue | $ 1,196,980 | $ 1,116,898 | $ 3,462,102 | $ 3,100,936 |
Cost of sales (exclusive of amortization shown separately below) | 496,387 | 490,824 | 1,497,350 | 1,340,660 |
Amortization of acquired intangible assets | 7,812 | 8,322 | 24,976 | 22,001 |
Total cost of sales | 504,199 | 499,146 | 1,522,326 | 1,362,661 |
Gross profit | 692,781 | 617,752 | 1,939,776 | 1,738,275 |
Operating Expenses | ||||
Selling, general, and administrative | 229,919 | 228,457 | 674,948 | 633,317 |
Research and development | 77,074 | 76,436 | 226,664 | 209,498 |
Amortization of acquired intangible assets | 11,204 | 12,188 | 35,259 | 29,701 |
Restructuring expenses (note 11) | 0 | 0 | 64,228 | 0 |
Acquisition related expenses | 0 | 0 | 0 | 9,157 |
Total operating expenses | 318,197 | 317,081 | 1,001,099 | 881,673 |
Income from operations | 374,584 | 300,671 | 938,677 | 856,602 |
Other income (loss), net: | ||||
Interest (expense) income, net | (11,026) | (14,964) | (39,787) | (32,436) |
Gain (loss) attributable to equity method investments (note 5) | 440 | (183) | (2,716) | (5,037) |
Gain on equity investments (note 5) | 13,919 | 6,418 | 11,429 | 11,506 |
Other, net | (2,496) | (2,564) | (537) | (5,773) |
Total other income (loss), net | 837 | (11,293) | (31,611) | (31,740) |
Income before income taxes | 375,421 | 289,378 | 907,066 | 824,862 |
Income taxes | 74,929 | 56,878 | 178,351 | 156,970 |
Net income | $ 300,492 | $ 232,500 | $ 728,715 | $ 667,892 |
Basic earnings per share (in dollars per share) | $ 2.04 | $ 1.58 | $ 4.96 | $ 4.55 |
Diluted earnings per share (in dollars per share) | 2.04 | 1.58 | 4.94 | 4.53 |
Dividend declared per share (in dollars per share) | $ 0.48 | $ 0.44 | $ 1.44 | $ 1.32 |
Basic shares outstanding (000's) (in shares) | 146,959 | 146,914 | 147,056 | 146,681 |
Diluted shares outstanding (000's) (in shares) | 147,450 | 147,395 | 147,549 | 147,400 |
Total Sleep and Respiratory Care | ||||
Net revenue | $ 1,049,023 | $ 980,116 | $ 3,029,915 | $ 2,741,541 |
Cost of sales (exclusive of amortization shown separately below) | 448,434 | 443,925 | 1,353,615 | 1,214,072 |
Amortization of acquired intangible assets | 1,054 | 1,367 | 4,294 | 3,939 |
Software as a Service | ||||
Net revenue | 147,957 | 136,782 | 432,187 | 359,395 |
Cost of sales (exclusive of amortization shown separately below) | 47,953 | 46,899 | 143,735 | 126,588 |
Amortization of acquired intangible assets | $ 6,758 | $ 6,955 | $ 20,682 | $ 18,062 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Jun. 30, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 237,910 | $ 227,891 |
Accounts receivable, net of allowances of $19,810 and $23,603 at March 31, 2024 and June 30, 2023, respectively | 779,265 | 704,909 |
Inventories (note 3) | 829,458 | 998,012 |
Prepaid expenses and other current assets (note 3) | 504,663 | 437,018 |
Total current assets | 2,351,296 | 2,367,830 |
Non-current assets: | ||
Property, plant and equipment, net (note 3) | 539,743 | 537,856 |
Operating lease right-of-use assets | 147,075 | 127,955 |
Goodwill (note 4) | 2,835,993 | 2,770,299 |
Other intangible assets, net (note 3) | 501,024 | 552,341 |
Deferred income taxes | 162,106 | 132,974 |
Prepaid taxes and other non-current assets | 277,325 | 262,453 |
Total non-current assets | 4,463,266 | 4,383,878 |
Total assets | 6,814,562 | 6,751,708 |
Current liabilities: | ||
Accounts payable | 177,445 | 150,756 |
Accrued expenses | 356,076 | 365,660 |
Operating lease liabilities, current | 24,182 | 21,919 |
Deferred revenue | 150,753 | 138,072 |
Income taxes payable | 54,671 | 72,224 |
Short-term debt, net (note 7) | 9,903 | 9,902 |
Total current liabilities | 773,030 | 758,533 |
Non-current liabilities: | ||
Deferred revenue | 131,981 | 119,186 |
Deferred income taxes | 86,564 | 90,650 |
Operating lease liabilities, non-current | 136,313 | 116,853 |
Other long-term liabilities | 47,550 | 68,166 |
Long-term debt, net (note 7) | 997,047 | 1,431,234 |
Long-term income taxes payable | 12,157 | 37,183 |
Total non-current liabilities | 1,411,612 | 1,863,272 |
Total liabilities | 2,184,642 | 2,621,805 |
Commitments and contingencies (note 9) | ||
Stockholders’ equity: | ||
Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued | 0 | 0 |
Common stock, $0.004 par value, 350,000,000 shares authorized; 189,319,079 issued and 146,886,657 outstanding at March 31, 2024 and 188,900,583 issued and 147,064,349 outstanding at June 30, 2023 | 588 | 588 |
Additional paid-in capital | 1,847,938 | 1,772,083 |
Retained earnings | 4,769,963 | 4,253,016 |
Treasury stock, at cost, 42,432,422 shares at March 31, 2024 and 41,836,234 shares at June 30, 2023 | (1,723,263) | (1,623,256) |
Accumulated other comprehensive loss | (265,306) | (272,528) |
Total stockholders’ equity | 4,629,920 | 4,129,903 |
Total liabilities and stockholders’ equity | $ 6,814,562 | $ 6,751,708 |